cphi south east asia

Gerresheimer to Showcase Latest News and Innovations at CPhI South East Asia

Gerresheimer has announced it will be attending CPhI South East Asia, where it will be showcasing a range of innovations and company news, including the opening of its new tubular glass production...

Indonesia: Pharma digitalization at CPhI SEA in March

JAKARTA, Indonesia. In two weeks’ time, from March 22-24, CPhI SEA is set to open its doors at Jakarta International Expo, offering to over 200 exhibitors the only dedicated pharma trading platform...
CPhI SEA Jakarta

Indonesia: Pharma Investment Forum at CPhI in March

By invitation only, the forum matches international players interested in investing in the region with the key local pharma companies looking for reliable partners. JAKARTA, Indonesia. In one month’...
Scientist working at the laboratory

Pharma news: CPhI SEA – Who are the new exhibitors?

JAKARTA, Indonesia -- In less than 2 months' time, CPhI SEA is set to open its doors from March 22-24 at Jakarta International Expo, offering the only dedicated pharma trading platform for the region...

CPhI: Pharma in South East Asia wins through Innovation, M&A, JVs and strategic Partnerships to spur Markets Integration

JAKARTA, Jan. 13, 2017 /PRNewswire/ -- Over the last 10 years South East Asia (SEA) pharmaceutical markets have been developing rapidly (6% – 10% yoy) and are expected to deliver remarkable future...
pharma focus on south east asia

Pharma Focus on Indonesia and South East Asia: Meeting the Challenges of Highest Growing Markets

Exploring the pharma market in South East Asia? Watch the video that was taken during CPhI Worldwide 2016 where the Indonesian Pharmaceutical Association and the National Agency for Drug and Food...

Pharma Indonesia and India: A Stronger Partnership In The Making

Indonesia is changing at an increasing pace. New government stimuli and simplifications are being introduced with the aim, announced earlier in February by President Joko (Jokowi) Widodo, of climbing...

India Country Focus at Pharmaceutical Exhibition in Jakarta

Local and multinational drug makers will continue to see strong revenue growth from the Asia Pacific markets. The key factors being the sustained expansion of private healthcare, improving healthcare...